Although it has been reported that patients with an IDH mutant glioblastoma and methylated MGMT gene promoter had longer survival than patients with IDH wild-type glioblastoma and an unmethylated MGMT gene promoter [19]; their prognosis remains poor. Here, IDH1 is linked to glioblastoma.